Join
Live feed
·
INSIDERFilingvia Quantisnow
Halozyme Therapeutics Inc. logo

SVP, CHIEF LEGAL OFFICER Snyder Mark Howard converted options into 5,034 shares and covered exercise/tax liability with 2,715 shares, increasing direct ownership by 5% to 49,929 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.) and more on Quantisnow.

SVP, CHIEF LEGAL OFFICER Snyder Mark Howard converted options into 5,034 shares and covered exercise/tax liability with 2,715 shares, increasing direct ownership by 5% to 49,929 units (SEC Form 4) to satisfy withholding obligation | Quantisnow